BDPP Treatment for Mild Cognitive Impairment and Prediabetes

Mild cognitive impairment (MCI) is a condition in which an individual may have some memory decline but not enough to affect his or her ability to perform daily functions independently. Some but not all people who have MCI progress to Alzheimer's disease. Diabetes and prediabetes (a condition in which blood sugar levels are higher than normal, but not considered to be diabetic) have been shown to increase risk for cognitive decline and the development of Alzheimer's disease.